Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 1 hour 35 min ago

Norsk Hydro: Holding Onto And Adding More To This Winner

Thu, 12/18/2025 - 12:25

Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm

Thu, 12/18/2025 - 12:22

Harbor Mid Cap Core ETF Q3 2025 Commentary

Thu, 12/18/2025 - 12:21

2026 S&P 500 Outlook: AI Is Real, But Easy Money Is Gone

Thu, 12/18/2025 - 12:19

OCC removes consent order amendment against Citi

Thu, 12/18/2025 - 12:16

CLOZ: Floating-Rate Income-Hold Case

Thu, 12/18/2025 - 12:08

An Important Warning: Popular Income Stocks Are Getting Risky Here

Thu, 12/18/2025 - 12:05

Lagarde Reiterates The ECB Is In No Rush To Change Rates Anytime Soon

Thu, 12/18/2025 - 12:05

Takeda posts late-stage trial win for oral plaque psoriasis therapy

Thu, 12/18/2025 - 12:03

Trump Media Makes Major Energy Pivot

Thu, 12/18/2025 - 12:01

Helios Technologies: Signs Of Improvement, But Still Only A 'Hold'

Thu, 12/18/2025 - 11:59

Integra Resources Corp. (ITR:CA) Discusses DeLamar Project Feasibility Study Results and Project Evolution - Slideshow

Thu, 12/18/2025 - 11:58

Northeast Community Bancorp: Risks Have Increased, But Valuation Is Still Compelling

Thu, 12/18/2025 - 11:58

Hawkins tops the struggling commodity chemical industry in 2025

Thu, 12/18/2025 - 11:58

Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's

Thu, 12/18/2025 - 11:55

Darden: Still A Quality Hold

Thu, 12/18/2025 - 11:54

Specialty chemicals lag in 2025, but these 10 names have delivered standout gains

Thu, 12/18/2025 - 11:52

Hartford Strategic Income ETF Q3 2025 Commentary

Thu, 12/18/2025 - 11:52

Toast: Buy The Dip As This Company Maneuvers Past Industry Weakness

Thu, 12/18/2025 - 11:49

Kalaris Therapeutics: TH103 Trial Success And $50M Raise Set Stage For Growth

Thu, 12/18/2025 - 11:47

Pages